Enovix Corporation
$745.90M- Market cap
- $728.57M
- Debt
- +$529.37M
- Cash
- −$512.04M
Capital structure 58% equity / 42% debt · EV / Revenue 23.44x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: ENVX stock price at premium vs NEO $3.32 current versus $0.45 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NEO's multiple
Implied fair value · at ENVX's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ENVX FY 2025 (ended Dec 28, 2025) · NEO FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 58% equity / 42% debt · EV / Revenue 23.44x
Capital structure 87% equity / 13% debt · EV / Revenue 3.32x
NEO carries the larger enterprise value at $2.42B against $745.90M; NEO trades on the lower EV / Revenue multiple (3.32x vs 23.44x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Enovix Corporation · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
NeoGenomics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.95x
0.41x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
-4.48x
Cash and equivalents
Liquid reserves on the balance sheet
$512.04M
$159.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
QuantumScape Corp
ENVX vs QS
Eos Energy Enterprises, Inc.
ENVX vs EOSE
Microvast Holdings, Inc.
ENVX vs MVST
AEHR TEST SYSTEMS
ENVX vs AEHR
LABCORP HOLDINGS INC.
ENVX vs LH
QUEST DIAGNOSTICS INC
ENVX vs DGX
OPKO HEALTH, INC.
ENVX vs OPK
Guardant Health, Inc.
ENVX vs GH
Natera, Inc.
ENVX vs NTRA
EXACT SCIENCES CORP
ENVX vs EXAS
$529.37M
$341.86M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.